Publications
E. Fuente-Martín , C. García-Cáceres , M. Granado , M L. de Ceballos , M.A. Sánchez-Garrido, B. Sarman , Z.-W. Liu , M. O. Dietrich, M. Tena-Sempere , P. Argente-Arizón , F. Díaz , J. Argente, T. L. Horvath , J. A. Chowen. Leptin regulates glutamate transporters in hypothalamic astrocytes. J.Clin.Invest. 122 (2012): 3900-13. Free PMC article
A.M. Martín-Moreno, B. Brera, C. Spuch, E. Carro, L. García-García, M. Delgado, M.A. Pozo, N. Innamorato, A. Cuadrado, M. L. de Ceballos. Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers β-amyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice. J.Neuroinflamm. (2012) 9 (1):8. Free PMC article
C. Lemos, A. Valério-Fernandes, G. C. Ghisleni, S. G. Ferreira, C. Ledent, M. L. de Ceballos, A. Köfalvi. Impaired hippocampal glucoregulation in the cannabinoid CB1 receptor knockout mice as revealed by an optimized in vitro experimental approach. J Neurosci Methods 204 (2012) 366– 373
Pérez-González R, Alvira-Botero MX, Robayo O, Antequera D, Garzón M, Martín-Moreno AM, Brera B, de Ceballos ML, Carro E. Leptin gene therapy attenuates neuronal damages evoked by amyloid-β and rescues memory deficits in APP/PS1 mice. Gene Ther. 21 (2014) 298-308
Pascual AC, Martín-Moreno AM, Giusto NM, de Ceballos ML, Pasquaré SJ. Normal ageing in the rat and pathological ageing in human Alzheimer’s disease decreases FAAH activity: Modulation by cannabinoid agonists. Exp.Geront. 60 (2014) 92-99
Nieto E, Delgado M, Sobrado M, de Ceballos ML, Alajarín R, García-García L, Kelly J, Lizasoain I, Pozo MA , Álvarez-Builla J. Preliminary research on 1-(4-bromo-2-nitroimidazol-1-yl)-3-[18F]fluoropropan-2-ol as a novel brain hypoxia PET tracer in a rodent model of stroke. Eur.J.Med.Chem. 101 (2015) 604-615
E. Fuente-Martín, C. García-Cáceres, P. Argente-Arizón, F. Díaz, M. Granado, D.Castro-González, M. L. de Ceballos, S. L. Dickson, J.Argente, J. A. Chowen. Ghrelin Regulates Glucose and Glutamate Transporters in Hypothalamic Astrocytes. Scient. Rep. (2016) 6:23673
A. Köfalvi, C. Lemos, A. M. Martín-Moreno, B. S. Pinheiro, L. García-García, M. A. Pozo, Â. Valério-Fernandes, R. O. Beleza, P. Agostinho, R. J. Rodrigues, S. J. Pasquaré, R. A. Cunha, M. L. de Ceballos. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease. Neuropharmacology (2016pii: S0028-3908(16)30087-9. doi: 10.1016/j.neuropharm.2016.03.015. [Epub ahead of print]
Pajares M, Jiménez-Moreno N, García-Yagüe ÁJ, Escoll M, de Ceballos ML, Van Leuven F, Rábano A, Yamamoto M, Rojo AI, Cuadrado A. Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy. 2016 Jul 18:0. [Epub ahead of print]
J.- J. Navarro-Dorado, N. Villalba, D. Prieto, B. Brera, A. M. Martín-Moreno, T. Tejerina, M. L. de Ceballos. Vascular dysfunction in a transgenic model of Alzheimer’s disease: Effects of CB1R and CB2R cannabinoid agonists. Frontiers in Neuroscience (2016) 16 September 2016 | http://dx.doi.org/10.3389/fnins.2016.00422
P.Pérez-Domper, V. Palomo, S. Gradari, C. Gil, M. L de Ceballos, A. Martínez, J.L. Trejo. The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis. Neuropharmacology 116 (2017) 174-187
S.Ballesteros, J. Mayas, E. Ruíz, A. Prieto, P. Toril, L. Ponce de León, M. L. de Ceballos, J. M. Reales. Effects of video game training on behavioral and electrophysiological measures of attention and memory: Protocol for a randomized controlled trial. JMIR Res.Protocols (2017) 6(1):e8. doi: 10.2196/resprot.6570
Books, book chapters and reviews:
A.Alsasua, E.Blanco, P.D’Ocón, C.C.Faura, M.C. Iglesias-Osma, M.L.de Ceballos, M.T.Tejerina. Aportaciones de los medicamentos a la salud y calidad de vida de los pacientes (II). Actualidad en Farmacología y Terapéutica 9 (2012) 198-209. R
M.L.de Ceballos. Cannabinoids for the treatment of Neuroinflammation. In: Cannabinoids in Neurological and Mental diseases. (L.Fattore, ed.), Amsterdam, Holanda: Elsevier pp 3-14 (2015). CL.
M.L.de Ceballos, Köfalvi A. Boosting brain glucose metabolism to fight neurodegeneration? Oncotarget. 2017 Feb 6. doi: 10.18632/oncotarget.15131. [Epub ahead of print]. Editorial.
|